S.D. lawmakers off to slow start in regulating legal weed, but industry ramping up
Marijuana Industry NewsRecreational Marijuana January 19, 2021 0
Entrepreneurs across South Dakota are already taking steps to claim a share of the state’s soon-to-be-legal marijuana market, but legislators and regulators are off to a slow start in crafting laws and rules to govern the controversial new industry. The sale, possession and use of recreational and medicinal marijuana... Read more
Could Arizona Dispensaries Start Selling Recreational Pot Soon? Like, Really Soon?
ArizonaMarijuana Industry NewsRecreational Marijuana January 19, 2021 0
We know a few things about how the sale of recreational marijuana will begin in Arizona, following the successful effort to legalize it in November. We know that Tuesday, January 19 — that’s tomorrow — is the day the state will begin accepting applications for licenses from businesses that wish... Read more
Skykit Unveils New Products to Help Organizations Adapt to 2021 Business Conditions
Marijuana Industry News January 19, 2021 0
PRESS RELEASE MINNEAPOLIS, MN – Innovative digital signage solution provider Skykit recently launched a series of new products to better serve the changing needs of organizations in 2021. From touchless check-in technology to critical communications shared instantly across thousands of screens, the company is reimagining the workplace experience –... Read more
Restrictions on shipment of vaping products could impact hemp industry
FeaturedIndustrial Hemp NewsMarijuana Laws, Regulations, & Politics January 19, 2021 0
Companies selling vaping products online, including those with CBD cartridges, will be forced to find an alternative to the U.S. Postal Service to ship their products and will face additional regulations come this summer. That’s because in late December, when Congress approved another appropriations bill to keep the government... Read more
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Empower Clinics Announces First Ever AGORACOM Video Q&A with Shareholders Submitting Questions for Direct Response by CEO Steven McAuley
January 19, 2021
Ryan Allway January 19th, 2021 Psychedelics EMPOWER CLINICS INC. (CBDT:CSE) (8EC:Frankfurt) (EPWCF:OTCQB) (“Empower“) an integrated healthcare company serving patients through medical clinics in USA and Canada, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA... Read more
Former LifeLabs COO Joins Novamind Leadership Team
January 19, 2021
Ryan Allway January 19th, 2021 Psychedelics Novamind Inc., (CSE:NM) (“Novamind”) a mental health company specialized in psychedelic medicine, announces the expansion of its leadership team with the appointment of Pierre Bou-Mansour, P.Eng., to the role of Chief Operating Officer. Effective immediately, Mr. Bou-Mansour will assume responsibility for ensuring operational... Read more
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Ketamine Formulation Targeting Mental Health, Neurological and Pain Disorders
January 19, 2021
Ryan Allway January 19th, 2021 Psychedelics Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that PharmaTher has entered into an Exclusive Worldwide License... Read more
Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development
January 19, 2021
Ryan Allway January 19th, 2021 Psychedelics Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (OTC Pink: ENTBF) (“Entheon“), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced a partnership with Divergence Neuro Technologies Inc. (“Divergence”), a company focused on the research and development of a data-driven, cloud-based... Read more
